Mapping large numbers of results may take a few moments.
|Company StrideBio Inc.||Activity: Research and Development||Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs).||Location Research Triangle Park|
|Company Baebies Inc.||Activity: Production and Manufacturing||Company Description Baebies develops and commercializes products and services based on digital microfluidics and other technology that ensure early disease detection and comprehensive diagnosis for children.||Location Durham|
|Company Cellectis||Activity: Production and Manufacturing||Company Description Cellectis develops blood and bone marrow cancer cell therapies. The Raleigh location is its North American manufacturing plant.||Location Raleigh|
|Company Eisai Inc.||Activity: Sales and Operations||Company Description Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company.||Location Raleigh|
|Company Foundation Medicine Inc.||Activity: Research and Development||Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials.||Location Morrisville|